News Related to Patritumab Deruxtecan

Related coverage linked through entity extraction aliases.

Breast Cancer Research Advances: New Drug Trials and Resistance Mechanisms Identified

Mar 20, 2026

Recent developments in breast cancer treatment include new clinical trials for advanced disease, findings on CDK4/6 inhibitor sequencing, and discovery of genetic markers explaining drug resistance in HER2-positive breast cancer.

Daiichi Sankyo Names John Tsai as New Global Head of R&D

Feb 20, 2026

Former Novartis executive John Tsai has been appointed global head of R&D at Daiichi Sankyo, replacing Ken Takeshita effective April 1. Tsai brings over 25 years of leadership experience in drug development.